GHK-Cu skin research has a few loose threads.
The copper caught my attention. Then I noticed how often a finding about a cream became a claim about an injection. I wanted to slow that leap down.
The copper is part of the name
A peptide is a short chain of protein building blocks. GHK has three; GHK-Cu is that chain holding copper. On skincare labels, you'll often see it called Copper Tripeptide-1.
In laboratory skin research, GHK-Cu helped cells make collagen, a protein that supports skin. That explains some of the interest. It doesn't tell us whether a particular cream will make someone's skin look firmer.
Getting the ingredient through skin is another hurdle. The review of wrinkle research discusses that problem. An ingredient can sound promising and still be difficult to deliver where it's meant to act.
I also check whether a paper used GHK or copper-bound GHK-Cu. The names are close, but they aren't interchangeable. The finding belongs to the substance tested.
Did anyone measure a change in people?
The small studies tell a mixed story
The earlier review reports improvements in firmness and wrinkles with some creams. Those findings are worth reading, with a catch: some original reports were conference material or a book chapter. There's less detail to examine than in a full trial paper.
In a small trial following laser skin treatment, the groups showed no statistically clear difference in redness or wrinkle improvement. People using the copper-peptide skincare were more satisfied, though. Feeling happier with a result and measuring a visible difference can be two separate things.
A test on donated human skin found that copper entered and stayed in skin layers. That was lab work on skin samples. It wasn't a test of wrinkle changes in living people.
A cream and an injection need separate safety answers.
Where the safety questions remain
Skin irritation is possible with topical copper peptides. Small studies also leave room for uncommon problems to go unnoticed. They can't establish safety for injections.
On the FDA page current as of April 22, 2026, injectable GHK-Cu is listed as nominated but withdrawn. The requests were withdrawn; FDA didn't clear or approve it. The agency still flags possible immune reactions linked to clumping and peptide impurities, with limited human safety data.
GHK-Cu isn't an FDA-approved medicine in any form. For a skin concern, a licensed U.S. clinician can discuss the actual problem and available care. Prescription access doesn't settle the skin-care question. Promise Peptides handles prescription requests for compounded GHK-Cu through telehealth at mypromise.com, with care only available in the U.S. Each request goes to a licensed clinician who reviews whether to prescribe; some people may not qualify, and compounded GHK-Cu is not FDA-approved. The GLOW page looks at what changes when other peptides join the mix.